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 Abstract 
 
Cervical cancer is the most common human papilloma virus (HPV) -associated cancer 
and is the second leading cause of death in the world. Vaccination against HPV is 
essential to reduce the incidence of HPV and subsequent morbidity and mortality. 
According to the Centers for Disease Control and Prevention (CDC), approximately 79 
million Americans are currently infected with HPV. The site for this DNP project was a 
163-bed facility with inpatient and outpatient services in the southern United States. The 
vaccination rate at the site was 48%. The facility lacked educational interventions to 
prepare and remind providers to offer HPV vaccine. The purpose of this DNP project was 
to address a significant gap by increasing clinician knowledge through the development 
of educational materials, the design and implementation of training sessions for staff, and 
the development of protocols that require providers to offer the vaccine to every eligible 
patient and to call the patient and remind them of appointments for vaccine injections. 
The academic center for evidence-based practice star model was used to translate 
knowledge into nursing practice to improve outcomes change. For this project, a panel of 
10 experts from the facility was formed to conduct a formative and summative evaluation 
of the educational materials and protocols. The findings of the study showed an 
acceptance of the plan suggesting the importance of the educational materials and the 
educational process to increase HPV vaccination rates, which can thereby reduce death 
and disease associated with HPV through the empowerment of the clinicians to provide 
necessary and appropriate care.   
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Section 1: Nature of the Project 
 
Introduction 
 
The human papillomavirus (HPV) is the most common sexually transmitted 
infection. There are more than 40 types of HPV that can infect the genital area, mouth, 
and throat. More than 50% of sexually active individuals will be diagnosed with genital 
HPV at some point in their lives (Dunne et al., 2014). Studies show that 66% of cervical 
cancers, 55% of vaginal cancers, 79% of anal cancers, and 62% of oropharyngeal cancers 
are attributable to HPV Types 16 or 18 (Dunne et al., 2014). Cervical cancer is the second 
leading cause of cancer deaths among women around the world (Petrosky et al., 2015). 
The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease 
Control (CDC) recommend that routine HPV vaccination be initiated at ages 11 or 12 
years. However, the vaccination series can be started as early as age 9 years. Females 
aged 13 through 26 years and males aged 13 through 21 years who have not already 
received the vaccine or completed the three-dose series should also be vaccinated. Males 
aged 22 through 26 years, particularly those who are high risk, can also receive the 
vaccine (Petrosky et al., 2015). Although vaccines are available, the HPV vaccination 
rate remains low. The vaccination rate at the project facility was 48%, which is below the 
Healthy People 2020 goal of 80% (Hariri et al., 2014). Developing interventions to 
improve HPV vaccination at this facility can decrease the risk for HPV, associated 
cancers, and death. 
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The U.S. Food and Drug Administration (FDA) approved Gardasil in 2006 to 
prevent HPV Types 6, 11, 16, and 18. These HPV types can cause cervical cancer, anal 
cancer, and genital warts. At that time, the Gardasil vaccine was recommended for use in 
females ages 9 to 26 years and was not recommended for males (FDA, 2015b). In 2009, 
the FDA approved Gardasil for use in males ages 9 to 26 years to prevent genital warts 
caused by HPV Types 6 and 11 (FDA, 2015b). The FDA approved Cervarix in 2009 for 
females 10 to 25 years of age for the prevention of HPV types 16 and 18 (FDA, 2015a). 
In 2014, Gardasil 9 was approved for females ages 9 to 26 years and males ages 9 to 15 
years for the prevention of cervical, vulvar, vaginal, and anal cancers caused by HPV 
Types 16, 18, 31, 33, 45, 52, and 58. The five additional HPV types covered by Gardasil 
9 are not covered by the previously approved vaccines (FDA, 2014). HPV vaccination 
consists of three injections administered in the course of 6 months (CDC, 2015). 
The project location was the women’s clinic at a 163-bed medical center in the 
southern United States. The medical center provides primary, secondary, and tertiary 
medical, neurological, and mental health inpatient care as well as a variety of specialized 
outpatient services. Female veterans have access to comprehensive health care through 
the clinic and that includes cervical and breast cancer screenings and HPV vaccine (U.S. 
Department of Veterans Affairs, 2015). The target population for this project was 
clinicians caring for female veterans ages 18 to 26 years at the facility. HPV is most 
common in individuals in their late teens and early 20s. Most men who contract 
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HPV never have symptoms and most cases usually resolve without intervention (CDC, 
2015). Costs, a perception that the vaccine is not beneficial, fear, side effects, and 
recommendation of a health care provider can affect vaccine acceptance (Rambout et al., 
2014). 
Problem Statement 
 
Although HPV vaccines are available, vaccination rates remain low. According to 
the CDC (2013), individuals are not receiving HPV vaccine when they receive other 
recommended vaccines. In 2009, a national immunization survey administered by the 
CDC revealed that HPV vaccination coverage among females ages 18 to 26 years was 
17.1% (CDC, 2011). In 2013, girls ages 13 to 17 years who received at least one dose of 
HPV vaccine was 57.3%, whereas 91.3% of girls age 13 years would have received at 
least one dose of HPV vaccine had they received it at the same time they received other 
recommended vaccines (CDC, 2013). The target population for this project was clinicians 
caring for female veterans ages 18 to 26 years at the VA facility. The vaccination rate at 
the Jackson VAMC was 48%. Eligible patients at the facility were not accepting the 
vaccine. Healthy People 2020 goals include 80% coverage of three doses of HPV 
vaccines for females by ages 13 to 15 years and to reduce the death rate from cancer of 
uterine cervix below a target of 2.2 deaths per 100,000 females from a baseline of 2.4 
deaths per 100,000 females in 2007. There is also a goal to increase the number of 
women who receive cervical cancer screening with a target of 0% of women ages 21 to 
65 years from a baseline of 84.5% in 2008 (Hariri et al., 2014). Vaccination before 
exposure to HPV will optimize the vaccine’s effectiveness (CDC, 2014). 
The problem that I addressed in this project was the lack of education related to 
HPV and its vaccines at the site. The significance of this DNP project was the 
development of evidence-based protocols and interventions to increase clinician 
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education and thereby increase vaccine acceptance among patients. 
Purpose Statement 
 
The purpose of this evidence-based project (EBP) was to develop interventions 
that would increase HPV awareness among patients and clinicians and thereby reduce the 
morbidity and mortality associated with HPV. 
Project Objectives 
 
The objectives for this project are as follows:  
Objective 1: Develop evidence- based educational materials for patients and 
clinicians concerning HPV and vaccination.  
Objective 2: Design and implement training sessions to prepare providers and 
nurses to offer HPV vaccine.  
Objective 3: Develop a protocol that requires providers to offer HPV vaccine 
during every encounter to eligible patients who have not received the vaccine.  
Objective 4: Develop a protocol that requires staff to call patients to remind 
them of appointments for follow-up vaccine injections. 
Nature of Doctoral Project 
 
The nature of the project was to address the low HPV vaccine acceptance rate. 
 
I developed evidence-based educational materials, training sessions, and protocols that 
would increase awareness and knowledge of HPV and vaccines. An expert panel 
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completed a formative evaluation on the educational interventions and provided feedback. 
The feedback improved the content validity and efficacy of the educational materials, 
training sessions, and protocols.  I gave these materials to the facility for future use. 
Evidence-Based Significance of the Project 
 
HPV vaccination has proven effective in preventing HPV infections in women as 
well as cancers associated with it. Knowledge can affect HPV vaccine acceptance. 
Provider recommendation has been found to be one of the strongest predictors of 
vaccination (Conroy et al., 2009). According to Cates et al. (2009), low intention to 
accept HPV vaccine among African Americans was associated with lower levels of 
knowledge about HPV and cervical cancer. Women were also found to have limited 
knowledge about HPV and vaccination (Kwan et al., 2009). Developing evidence-based 
interventions to educate health care professionals and establish protocols can increase 
knowledge of HPV and available vaccines among providers and thereby increase 
vaccination and reduce the death and disease associated with it (CDC, 2014). Preventing 
HPV and cancers will also reduce costs associated with follow-up procedures and 
treatments (ACOG, 2015). 
Implications for Social Change in Practice 
 
Walden University defines positive social change as “a deliberate process of 
creating and applying ideas, strategies, and actions to promote the worth, dignity, and 
development of individuals, communities, organizations, institutions, cultures, and 
societies” (Walden University, 2014, p.1). The interventions in this project were 
6 
 
 
 
designed to raise awareness and provide education for health care providers concerning 
HPV and available vaccines. This increased knowledge can be used to educate patients 
and increase their likelihood of accepting HPV vaccine, thereby reducing the burden 
associated with HPV.  Male and female patients at risk for HPV will benefit from this 
research through the evidence-based guidelines designed to improve acceptance of 
HPV vaccine.  Vaccinated male and female patients will have a reduced likelihood of 
contracting HPV thereby increasing their opportunities for longer, healthier lives.   
They will also avoid costs associated with treatment of HPV-associated conditions.  
These healthy individuals can contribute to society through the development of self and 
working in their organizations and communities.  I also designed this project to 
increase the ability of the organization to sustain changes in practice and continue to 
identify and address practice problems. 
Definitions of Terms 
 
An attitude is a way of thinking or perception that makes one behave in a certain 
way (Merriam-Webster, 2018a).  
A barrier is an object, real or perceived, which can prevent one from performing 
a behavior (Rosentsock, 1974). 
Education is the action or process of gaining knowledge and skill from study or 
training (Merriam-Webster, 2018b). 
Human Papillomavirus is a group of more than 150 viruses that can cause warts 
or cancer. There are more than 40 types of HPV. It is the most commonly sexually 
transmitted infection and is spread through intimate skin-to-skin contact (CDC, 2015). 
HPV vaccination is a vaccination given to protect against HPV and the potential 
health problems associated with HPV infection (CDC, 2015). 
Perception is the way in which one understands someone or something 
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(Merriam-Webster, 2018c). 
Seriousness is the possibility of being dangerous (Merriam-Webster, 
2018d). 
Susceptibility is the state of being affected or hurt by something 
(Merriam-Webster, 2018e). 
Assumptions and Limitations 
 
The major assumption that I made in this study was that stakeholders would want 
to implement the project plan and sustain it after the project was complete. I also 
assumed that the rate of HPV vaccine acceptance would increase among young adult 
women ages 18 to 26 years who are eligible to receive the vaccine. An additional 
assumption was that after educating nurses and providers, they would offer the vaccine 
to each eligible patient, identify potential and actual barriers, and develop a plan to 
reduce or eliminate those barriers. 
One can furthermore assume that education and knowledge can lead to behavior 
change. A limitation of this study was that the results may not be generalizable to other 
locations or populations. Only health care providers at the women’s clinic at the project 
facility received education, training, and protocols. The study did not include adult 
males or adolescent males or females. 
Summary 
 
HPV affects millions worldwide, increasing their risk for cervical cancer. HPV 
vaccine acceptance rates remain low, despite available vaccines. It is essential to 
vaccinate individuals before exposure so that immunity to HPV can be developed. The 
purpose of this EBP was to effectively design interventions and protocols aimed at 
increasing the knowledge of HPV and available vaccines among health care providers.
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Section 2: Background and Context 
 
Introduction 
 
HPV is the most common sexually transmitted infection and is associated with 
several types of cancer. Although vaccines to protect against HPV are available, vaccine 
acceptance remains low. The purpose of this EBP was to raise awareness of HPV and 
vaccines among patients and clinicians and to develop measures that will increase HPV 
vaccine acceptance among females ages 18 to 26 years. I will also explain the theoretical 
framework that I used to guide this project. The HPV vaccination rate at the project site 
was 48% which is significantly below the Healthy People 2020 goal of 80% (Hariri et al., 
2014). Low vaccination rates have been associated with various barriers, which include a 
lack of provider and patient knowledge, side effects, costs, lack of time, and a belief that 
the vaccine is not needed by individuals who are not sexually active (Al-Dubai et al., 
2010; Downs et al., 2010; Paul, LaMontagne, & Le, 2012; Rose, Lanumata, & Lawton, 
2011). Research shows that motivators to receiving HPV vaccine include education from 
a credible source and advice from individuals who had received the vaccine (Downs et 
al., 2010). Developing interventions to improve HPV vaccination at this facility can 
decrease the risk for HPV, associated cancers, and death. 
The evidence-based interventions that I designed for this project were based on the 
health belief model (HBM). Interventions designed to increase knowledge concerning 
HPV and available vaccines among health care providers can better equip them to assess 
and address a patient’s perceived seriousness of HPV, perceived susceptibility to HPV, 
perceived benefits of HPV vaccination, and perceived barriers to HPV vaccination, which 
can increase the acceptance of HPV vaccine among veterans and thereby decrease the 
morbidity and mortality associated with it. 
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Conceptual Model and Theoretical Framework 
 
I used the academic center for evidence-based practice (ACE) star model as a 
framework for developing the interventions and protocols that will translate knowledge 
into nursing practice to improve outcomes (Appendix D). The model consists of five 
steps: finding new knowledge, summary of evidence, incorporating evidence into 
practice, implementation of practice change, and evaluation of the effects of practice 
change (Schaffer, Sandau, & Diedrick, 2013). The HBM is based on the concept that 
health behavior is determined by personal beliefs, perceptions about a disease, and 
measures to decrease its occurrence (Appendix E). Originally developed in the 1950s by 
social psychologists Hochbaum, Rosenstock, and Kegels to determine the reason for 
unsuccessful medical screening programs offered by the U.S. Public Health Service, the 
HBM is the most commonly used theory in health education and health promotion 
(Rosenstock, 1966). The model is composed of four main perceptions: perceived 
seriousness, perceived susceptibility, perceived benefits, and perceived barriers 
(Rosenstock, 1966). Each perception can be used either individually or in combination to 
explain health behavior such as the acceptance of the HPV vaccination (Sharma & 
Romas, 2012). I could not find studies that cited the title by Rosenstock, Hochbaum, or 
Kegels until Rosenstock’s 1966 work (Rosenstock, 1966). A perceived barrier is the 
most significant construct determining human behavior change (Janz & Becker, 1984). 
In the HBM, perceived barriers and benefits of a behavior influence one’s likelihood of 
taking recommended action (Sharma & Romas, 2012). 
Relevance to Nursing Practice 
 
Health care providers, media, and other sources can influence an individual’s 
hesitancy towards vaccination. Hesitancy is a concern or doubt about the benefit or safety 
of vaccine. Lack of knowledge and trust can play a role in vaccination attitudes (Yaqub 
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et al., 2014). Head, Vanderpool, and Mills (2013) conducted a study to explore the 
perspectives of health care providers in Appalachian Kentucky on barriers and facilitators 
to HPV vaccination and their recommendations for improving vaccination rates. Previous 
research in Appalachian Kentucky had revealed a low uptake and adherence to HPV 
vaccination among females ages 18 to 26 years, even though the vaccine was offered at 
no cost. The results revealed that poor communication and a lack of HPV vaccine 
education were the primary reasons for low acceptance. The researchers concluded that 
more targeted education efforts and patient-centered reminder systems could prove 
beneficial in increasing vaccine acceptance and adherence.  
Wong et al. (2013) conducted a study among primary care physicians in Hong 
Kong to assess knowledge toward, attitude toward, practices of, and barriers to 
recommending HPV vaccines. They found that knowledge of HPV infection was low 
among physicians and concluded that educational initiatives should target physicians 
(Wong et al., 2013). Research has also shown that individuals are more likely to accept 
HPV vaccine if a clinician recommended the vaccine to them (Kang & Moneyham, 
2010). Studies have also shown that vaccine recall and reminder systems have proven 
effective in increasing vaccine acceptance rates (Conroy et al., 2009). 
The evidence-based interventions that I designed for this project were based on 
the HBM, which is composed of four main concepts: perceived seriousness, perceived 
susceptibility, perceived benefits, and perceived barriers; these concepts can explain 
health behaviors, such as the acceptance of the HPV vaccination (Gerend & Shepherd, 
2012). Interventions that were designed to increase knowledge concerning HPV and 
available vaccines among VA health care providers can better equip them to assess and 
address a patient’s perceived seriousness of HPV, perceived susceptibility to HPV, 
perceived benefits of HPV vaccination, and perceived barriers to HPV vaccination, 
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which can increase the acceptance of HPV vaccine among veterans and thereby decrease 
the morbidity and mortality associated with it. 
Local Background and Context 
 
A lack of awareness of HPV and available vaccines among clinicians at the 
project facility was a barrier to HPV vaccine acceptance among patients. It was therefore 
essential to develop educational materials and protocols. The target population for this 
project was clinicians caring for female veterans ages 18 to 26 years at the VA project 
facility. The HPV vaccination rate was 48%. It is essential that clinicians have evidence-
based guidelines for their practice so that they can educate patients. The evidence-based 
education materials in this project reflected CDC standards. 
Role of the DNP Student 
 
As a DNP student, my role in this project was to provide the facility with 
evidence-based educational materials, training session plan, protocols, and a long-term 
evaluation method for future use when the items were implemented.  I designed the 
educational materials to increase the staff’s knowledge of HPV and available vaccines. 
Furthermore, I developed the materials to teach staff how to identify and minimize or 
eliminate potential barriers to vaccination. The protocols that I developed require staff to 
call and remind patients of follow-up appointments. Other protocols require providers to 
offer the vaccine to every eligible patient. As a student, I developed educational 
materials, training plans, and protocols. I also developed a panel of experts for a 
formative evaluation of the educational materials, training session plans, and protocols 
to increase validity. 
Summary 
 
Research has shown that HPV can cause several types of cancers, including 
cervical cancer. HPV vaccines can protect against certain types of HPV and thereby 
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reduce one’s risk for the cancers associated with this disease. The HBM was the 
framework that I used to guide this project and develop interventions and a protocol that 
would raise awareness of HPV and vaccines to increase vaccine acceptance, and thereby 
decrease the morbidity and mortality associated with HPV. 
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Section 3: Collection and Analysis of Evidence 
 
Introduction 
 
I conducted an exhaustive review of the literature through the Walden University 
online library using Thoreau Multi-Database, CINAHL Plus with Full Text, and 
MEDLINE with Full Text.  The following key terms in the search were HPV, 
vaccination, acceptance, cervical cancer, facilitators, attitudes, and barriers. Exclusion 
criteria included articles greater than 10 years old and those written in a language other 
than English. Inclusion criteria included the terms HPV, vaccine, and education.  The 
review included studies concerning barriers to and attitudes towards HPV vaccination. 
This section outlines specific and general literature related to HPV and vaccines designed 
to protect it as well as measures that have proven effective in increasing vaccine 
acceptance. 
 
Practice-Focused Question 
 
The PICO format—patient population, intervention, comparison intervention or 
group, and outcome—served as a guideline for the development of an appropriate, 
relevant project question (Malhotra, 2013). The question for this project was as follows: 
Will evidence-based education and protocols increase HPV vaccine acceptance among 
young women ages 18 to 26 years? 
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Sources of Evidence 
 
Specific Literature 
 
Researchers have suggested that the HPV vaccine remains effective for at least 
10 years, and there has been no evidence to suggest that HPV vaccine loses its ability 
to protect against HPV with time. HPV vaccine is continuously monitored for safety 
and effectiveness. According to the CDC (2014), clinical trials have shown the 
vaccines provide 100% protection against precancers and genital warts. Since the 
approval and recommendation of vaccines in 2006, HPV infections have declined by 
56% in teenage girls in the United States. The incidence of genital warts has also 
decreased. In countries, such as Australia, that have greater HPV vaccination coverage, 
there has been a reduced incidence of precancers of the cervix among women in the 
country (CDC, 2014). 
Education, which can eliminate barriers while promoting vaccination, is an 
important part of health care. It is therefore essential that providers are educated and 
trained so that they can offer vaccines to eligible patients. Barriers to vaccination include 
cost, a perception that the vaccine is not necessary, and concerns about vaccine safety 
and side effects. Facilitators to vaccination include perceived benefit of vaccination, 
recommendation of a health care provider, and social norms (Rambout et al., 2014). 
Gorin and Westhoff (2009) identified specific level barriers. Provider level barriers are 
physician knowledge about HPV and physician recommendation that can have a strong 
influence on HPV vaccine acceptance. Some providers find it challenging to discuss 
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sexually transmitted infections, and others are reluctant to store a vaccine that is less 
often requested. Policy level barriers are access to health care, insurance coverage, 
vaccine availability, limited knowledge of HPV vaccine, and media coverage with 
stigmatizing effects. At the patient level, barriers include limited awareness of the 
vaccine; socioeconomic status; perception of risk based on sexual history; fear of vaccine 
safety; and socio-cultural, economic, and religious factors. Both providers and patients 
can benefit from further education on ways to effectively discuss sexually transmitted 
infections such as HPV and offer vaccinations (Gorin & Westhoff, 2009). 
Attitudes, beliefs, and behaviors related to HPV can also affect the acceptance 
of HPV vaccine. Bendik, Mayo, and Parker (2011) found a positive correlation between 
having received HPV vaccine and knowledge score. The researchers found that among 
those who had not received the vaccine, 35.4% revealed that “my doctor tells me to get 
it” would be a motivating factor, followed by “I find a way to pay for the vaccine” 
(19.5%), “my parents tell me to get it” (16.4%), “I become sexually active” (14%), and 
“I start having sex with more partners” (9.6%). Recommendations from parents and 
doctors in addition to perceiving HPV as severe were prevalent and strongly associated 
with previous vaccination. Results suggest that increased education about the vaccine 
and the importance of physician recommendation will prove beneficial in increasing 
vaccine acceptance (Bendik et al., 2011). Conroy et al. (2009) conducted a similar study 
to assess HPV vaccine uptake, predictors of vaccination, and barriers to vaccination 
among females ages 13 to 26 years at an urban clinic. The researchers concluded that 
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interventions to increase HPV vaccination rates should target costs, promote HPV 
vaccination as routine, and establish clinic-based systems to ensure that the vaccine is 
offered to eligible individuals (Conroy et al., 2009). Reminder/recall (R/R) messages 
have proven beneficial in increasing vaccination rates. Half of the parents of young 
children ages 19 to 35 months who participated in a study favored an R/R message with 
mail being the preferred method (Saville et al., 2014). Assigning a dedicated staff 
member to deliver R/R messages improves the likelihood of success (Saville et al., 2011) 
General Literature 
 
Electronic-derived immunization prompts have proven to increase vaccine uptake. 
 
Clinical decision support tools can serve as reminders for overdue immunizations. In a 
study conducted by Bundy et al. (2013), these prompts resulted in the highest rates for 
completion of HPV vaccination series in four of five quarters (Bundy et al., 2013). 
Protocols should be in place to guide providers to offer the vaccine to eligible patients. A 
study among young men ages 18 to 22 years from African American, Haitian, Caucasian, 
and Latino racial groups revealed perceived benefits as protection from anal and oral 
cancer, good health, and the prevention of disease transmission. These men were more 
likely to accept HPV vaccine when their concerns were addressed honestly during a 
doctor’s appointment. Perceived barriers to vaccination included lack of knowledge, side 
effects, fear of needles, and cost. Side effects such as bleeding and insanity were some of 
the concerns voiced by participants which highlighted the lack of knowledge among men 
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in these racial groups.  
Culturally competent education could prove beneficial in reducing the ethnic 
differences in attitudes, beliefs, and behaviors concerning vaccination among young men 
(Pierre et al., 2014). Other studies have confirmed that barriers to vaccination include a 
lack of awareness, fear of needles, fear of social stigma, lack of time, costs, 
inconvenience, and a belief that the vaccine is not needed if one is not sexually active 
(Al-Dubai et al., 2010; Downs et al., 2010; Paul et al., 2012; Rose et al., 2011). Downs et 
al. (2010) discovered that motivators for HPV vaccine acceptance among African 
American women were education, affordable prices, good results with the vaccine, and 
knowledge of individuals who had received HPV vaccine. Motivators among Latinas 
included having more than one credible source of information such as educational talks, 
doctor’s office, television, churches, and advice from women who had received the 
vaccine. Knowledge of perceived barriers to HPV vaccination is essential to the 
development of educational initiatives that will decrease existing disparities in cervical 
cancer incidence and mortality. 
Bastani et al. (2011) explored the low HPV vaccine acceptance rates in low-
income, ethnic minority, and immigrant populations in the United States. Between 
January 2009 and November 2009, 490 telephone interviews were conducted in six 
languages among mothers of vaccine-eligible girls ages 9 to 18 years using the Los 
Angeles County Department of Public Health, Office of Women’s Health service referral 
hotline. HPV and vaccine awareness, knowledge, beliefs, barriers, and daughters’ vaccine 
receipts were assessed. Only 29% of daughters initiated the vaccine 
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and 11% received all three doses. No ethnic differences were observed in initiation or 
completion rates. Ethnic differences were observed in HPV awareness, perceived risk, 
and other vaccine-related beliefs. Vaccine awareness was the strongest predictor of 
initiation (Bastani et al., 2011). For the barrier “need more information to make a 
decision,” 64% of the Latina population rated this as a barrier, whereas 81% of the 
Chinese, 66% of the Korean, and 41% of the African American populations also rated 
this as a barrier. A total of the 74% of the population rated “do not know where to go to 
get the vaccine” as a barrier, with 68% of the Latina, 84% of the Chinese, 81% of the 
Korean, and 68% of the African American populations agreeing with this statement. The 
barrier “thinks HPV vaccine may cause problems getting pregnant in the future” was 
noted by 17% of the total population, including 16% of the Latina, 19% of the Chinese, 
4% of the Korean, and 56% of the African American population. “Thinks HPV vaccine 
may cause health problems in the future” was rated as a barrier by 15% of the total 
participants. It was rated as a barrier by 11% of Latinas, 24% of Chinese, 4% of Koreans, 
and 44% of African Americans. Of the total mothers, 13% believed their daughters may 
think it is okay to have sex after getting the HPV vaccine; 11% of Latina mothers noted 
this barrier as significant, as did 15% of Chinese mothers, 0% of Korean mothers, and 
11% of African American mothers (Bastani et al., 2011). This study suggests that 
adequately trained health care professionals and established protocols that guide 
professionals to offer the vaccine can reduce barriers associated with HPV vaccine 
acceptance. 
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Analysis and Synthesis 
 
The purpose of this proposed project was to develop an educational intervention 
and protocol that would raise awareness of HPV and available vaccines among providers 
and establish protocols that will increase HPV vaccine acceptance among females ages 
18 to 26 years. I conducted a literature review. The evidence supported the development 
of a quality improvement project consisting of educational materials, a training session, 
protocols, and a long-term evaluation plan that will help providers and nurses offer HPV 
vaccine to every patient. I also formed a panel of experts to conduct a formative and 
summative evaluation of the educational materials and protocols. After obtaining 
institutional review board (IRB) approval, I presented the quality improvement project 
components to the expert panel in a classroom setting using a face-to-face approach and 
PowerPoint presentation (Appendix A).  The director of the women’s clinic provided 
contact information for health care professionals working in the women’s clinic. Each 
professional was notified via e-mail and informed of the problem identified in the 
women’s clinic. The 10 participants who volunteered to participate in the project were 
notified of the date, time, and location for the formative evaluation of the educational 
materials, training session, and protocols.  I emailed the presentation agenda 1 week prior 
to the presentation. 
Population and Sampling 
 
The population for this study was a 10-member expert panel consisting of 
clinicians in the women’s clinic at the facility. The sample included one doctor who 
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was medical director of the women’s clinic, two advanced practice nurses, six registered 
nurses, and one nurse educator. This sample was effective because I focused on 
education for health care providers.  The panel conducted a formative evaluation. 
Analysis of the answers provided by the respondents led to development of descriptive 
statistics that answers research questions. The formative and summative groups 
conducted a two-step process to evaluate the quality of the guideline prior to 
finalization of the guideline.  
Protection of Human Subjects 
 
For the protection of human subjects, I submitted the necessary paperwork to 
obtain approval from VA facility prior to developing educational interventions and 
protocols to improve HPV vaccination rates.  Walden University IRB also granted 
approval. 
Project Evaluation Plan 
 
The expert panel reviewed the materials for the Formative and Summative 
assessment.  Data collection was done using a tool based on the ADDIE.  The 
University of Texas Medical Branch at Galveston granted permission to use an adapted 
version of this tool (Appendix B). The validated ADDIE tool is both a quantitative and 
qualitative formative evaluation tool that provides data on the efficacy and content 
validity of projects. The survey contains 14 closed-ended questions 
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followed by an open-ended comment section.  The practice site received the results first. 
An expert panel conducted a formative evaluation of the educational materials and 
protocols that I developed and provided recommendations (Appendix C). I revised the 
materials and protocols based on the feedback. The expert panel conducted a final 
summative evaluation. The facility may choose to conduct a long-term evaluation, which 
will include facility data extracted from the electronic health record concerning HPV 
vaccination acceptance by women ages 18 to 26 years. 
Summary 
 
Reducing the burden associated with HPV will require unique interventions aimed 
at educating health care providers and establishing protocols to ensure that eligible 
patients are offered the vaccine and reminded of appointments. In this section, I addressed 
how this project will be developed and implemented in addition to measures that will be 
taken to evaluate effectiveness. 
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Section 4: Findings and Recommendations 
 
Introduction 
 
Data analysis leads to clear findings that answer research questions. The data 
collection tools influenced the nature of data that I used in this research. The findings are 
essential in reduction of the burden associated with HPV. In this section, I address the 
findings and implications from the collected data. 
Findings and Implications 
 
In the summative evaluation, all members of the committee approved the plan. 
 
The 10 respondents also conducted the formative evaluation. The target population for 
this project was clinicians caring for female veterans ages 18 to 26 years in a women’s 
clinic at a VA facility. The formative evaluation form is an indicator of the level of 
agreement. Each of the questions in the formative evaluation form had the same response 
for all the 10 respondents. The responses in this case were all in agreement. Formative 
evaluation involved evaluation of educational materials and protocols to improve HPV 
vaccination rates. Table 1 shows the responses in the formative evaluation. 
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Table 1 
Formative Group Questionnaire 
 
Question Response Number of participants 
Q1: Is the target audience clearly identified? Yes 10 
Q2: Is the educational level and job 
description of the participants aligned with 
the educational materials? 
Yes 10 
Q3: Is the job description of the participants 
aligned with the educational materials? 
Yes 10 
Q4: Is the educational material appropriate for 
the learner’s personal background (e.g., age, 
nationality, previous experiences, interests, 
cultural background)? 
Yes 10 
Q5: Does the educational material identify what 
the learner needs to accomplish at the end of the 
program? 
Yes 10 
Q6: Can you identify the desired outcomes to be 
achieved through this protocol? 
Yes 10 
Q7: Does this educational material address 
aspects of current practices that need to be 
improved upon? 
Yes 10 
Q8: Can you identify the instructional goals and 
target objectives for this program? 
Yes 10 
Q9: Will the described environment in which 
the program is to be conducted be a conductive 
learning environment? 
Yes 10 
Q10: Are there limiting factors that must be 
considered with regards to resources, technical 
support, time, technical skills, financial factors, 
and supporting factors that are needed to make 
this program successful? 
Yes 10 
Q11: Is the proposed educational media 
appropriate for the target audience? 
Yes 10 
Q12: Is the proposed time frame for the 
educational program appropriate? 
Yes 10 
Q13: Is the method to determine acquisition of 
acquired competencies appropriate? 
Yes 10 
Q14: Is the mechanism that will be used to 
obtain learners’ feedback on material learned 
appropriate? 
Yes 10 
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Each of the 10 members responded to all 14 questions. The questions asked were 
aligned with the objectives of the study. The answers of all respondents for all questions 
are similar. There was a 100% positive response for each question in evaluation of 
educational materials and protocols to improve HPV vaccination rates. The responses 
can generate descriptive statistics for each question to yield a conclusion. Evaluation of 
the information given by the formative group reveals a clear conclusion that there is 
agreement that the educational materials and protocols would greatly improve HPV 
vaccination rates. The percentage of agreement is at 100% meaning that the sample 
population is of the point of view that the educational materials would have a significant 
effect on HPV vaccination rate. The formative group provided recommendations for the 
development of educational materials in the comment boxes of the evaluation 
(Appendix B). The summative group responses outlined in Table 2 also show 100% 
agreement. 
 
Table 2 
Summative Group Questionnaire 
 
Question Response Number of participants 
Q1: Is the target audience clearly identified? Yes 10 
Q2: Is the educational level and job 
description of the participants aligned with 
the educational materials? 
Yes 10 
Q3: Is the job description of the participants 
aligned with the educational materials? 
Yes 10 
Q4: Is the educational material appropriate for 
the learner’s personal background (e.g., age, 
nationality, previous experiences, interests, 
cultural background)? 
Yes 10 
Q5: Does the educational material identify what 
the learner needs to accomplish at the end of the 
program? 
Yes 10 
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Q6: Can you identify the desired outcomes to be 
achieved through this protocol? 
Yes 10 
Q7: Does this educational material address 
aspects of current practices that need to be 
improved upon? 
Yes 10 
Q8: Can you identify the instructional goals and 
target objectives for this program? 
Yes 10 
Q9: Will the described environment in which 
the program is to be conducted be a conductive 
learning environment? 
Yes 10 
Q10: Are there limiting factors that must be 
considered with regards to resources, technical 
support, time, technical skills, financial factors, 
and supporting factors that are needed to make 
this program successful? 
Yes 10 
Q11: Is the proposed educational media 
appropriate for the target audience? 
Yes 10 
Q12: Is the proposed time frame for the 
educational program appropriate? 
Yes 10 
Q13: Is the method to determine acquisition of 
acquired competencies appropriate? 
Yes 10 
Q14: Is the mechanism that will be used to 
obtain learners’ feedback on material learned 
appropriate? 
Yes 10 
 
 
 
The findings of the study additionally show that HPV is the most common 
sexually transmitted infection and has been associated with several cancers. The research 
shows hesitancy toward vaccination and a low vaccination rate.  Cervical cancer is the 
second leading cause of death in the world.  Research suggests that there is need to 
improve HPV vaccination rates. Gardasil and Cervarix are among the available vaccines 
for the HPV virus. The potential barriers to HPV vaccination include the cost, limited 
awareness, and concerns about safety and side effects. The research shows that ways to 
minimize these barriers include routinely promoting HPV vaccination, exploring cost 
with insurance, and educating providers and patients about HPV. Summative and 
formative assessment suggests strong agreement that education material would improve 
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HPV vaccination rates by raising awareness. The summative evaluation had individuals 
who all agreed. All the individuals are care givers. 
Recommendations 
 
Educational protocols and interventions can prove beneficial in increasing vaccine 
acceptance. There is need to increase awareness on HPV vaccination. Reducing the 
burden associated with HPV requires unique interventions aimed at educating health care 
providers and establishing protocols to ensure that eligible patients are offered the 
vaccine and reminded of appointments. I recommend that clinicians in the project facility 
implement the educational materials and protocols into their practice and develop a long-
term evaluation plan to measure effectiveness. 
Project Strengths and Limitations 
 
My study has strengths and limitations. The methodology of the study is among 
the strengths. A limitation, however, is in the sample population being limited to 
clinicians in the women’s clinic who care for individuals of a specific age and gender. 
The target population for this project is clinicians caring for female veterans ages 18 to 
26 years at the VA facility. A limitation of this study is that the results may not be 
generalizable to other locations or populations. Only health care providers at the 
women’s clinic at the VA facility received education, training, and protocols. I did not 
include adult males or adolescent males or females in my study. The selected participants 
in the formative group are professionals. All the participants in the formative and 
summative groups returned their evaluations. Generalizability of a research is important 
in making it useful in different areas. There are aspects of the study that may be 
limitations or strengths depending on the point of view. 
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Section 5: Dissemination Plan 
 
Analysis of Self 
 
In my opinion, I did a thorough job with the project. My work remained 
objective and without bias. During the project, I received constructive criticism and used 
it to make improvements under the guidance of my committee. The 100% agreement by 
the summative group is an indicator of the effectiveness of the education material. I was 
satisfied with the presentation and gained new knowledge and skills from this research 
process. I will apply the knowledge and skills learned to improve in my role as a 
clinician. This project helped me to identify real and potential problems in practice, 
conduct a literature review, implement interventions based on evidence, and evaluate the 
effectiveness of those interventions before finally reaching a conclusion. 
 
Dissemination Plan 
 
The results of this DNP project will be presented during the National Research 
Week, a symposium where various clinicians present research projects completed at the 
facility.   I will use a poster presentation to present the findings. A PowerPoint 
presentation of the results will be delivered during a monthly meeting of the project 
facility’s Evidence-Based Research Committee. The results will also be published in the 
Federal Practitioner, which is a peer-reviewed journal for health care professionals of 
the VA. I also plan to present the results in a poster presentation at the Mississippi Nurses 
Association state conference and the American Association of Nurse Practitioners 
national conference. 
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Summary and Conclusions 
 
HPV is the most common sexually transmitted infection and has been associated 
with various types of cancer. Although vaccines to protect against HPV are available, 
vaccination rates remain low. The purpose of this project was to develop interventions 
and protocols based on evidence that will improve clinician knowledge of HPV and its 
vaccines. This improvement in education and knowledge can improve vaccine acceptance 
and thereby reduce the death and disease caused by the cancers associated with HPV. 
Trained clinicians who have been educated can identify eligible patients and offer the 
vaccine effectively. They can also identify and reduce or eliminate potential barriers to 
vaccination. Their actions will likely improve HPV vaccine acceptance and in turn reduce 
the incidence of HPV. In this project, I provided a short-term plan to improve knowledge 
of HPV and its vaccine. I also plan to assist with the development of a long-term 
evaluation plan, which will involve an extraction of data from the charts to measure any 
changes in the HPV vaccination rate at the VA facility. Dissemination of the results of 
this project will include professionals at the local, state, and national levels. 
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Appendix B: Evaluation of Educational Materials and Protocols to Improve HPV 
Vaccination Rates 
1. Is the target audience clearly identified? 
 
Yes   
No   
Comment: 
 
2. Is the educational level and job description of the participants aligned with the 
educational materials? 
 
Yes   
No   
Comment: 
 
3. Is the job description of the participants aligned with the educational 
materials? 
 
Yes   
No   
Comment: 
 
4. Is the educational material appropriate for the learner’s personal background 
(e.g., age, nationality, previous experiences, interests, cultural background)? 
 
Yes  
No   
Comment: 
 
5. Does the educational material identify what the learner needs to accomplish at 
the end of the program? 
 
Yes   
No   
Comment: 
 
6. Can you identify the desired outcomes to be achieved through this protocol? 
 
Yes   
No   
50 
Comment: 
 
 
 
 
7. Does this educational material address aspects of current practices that need to be 
improved upon? 
 
Yes   
No   
Comment: 
 
8. Can you identify the instructional goals and target objectives for this program? 
 
Yes  
No    
Comment: 
 
9. Will the described environment in which the program is to be conducted be a 
conductive learning environment? 
Yes   
No   
Comment: 
 
10. Are there limiting factors that must be considered with regards to resources, 
technical support, time, technical skills, financial factors, and supporting factors that 
are needed to make this program successful? 
Yes  
No   
 
 
11. Is the proposed educational media appropriate for the target audience? 
Yes   
No   
Comment: 
 
12. Is the proposed time frame for the educational program appropriate? 
Yes   
No   
Comment: 
51 
Comment: 
 
 
13. Is the method to determine acquisition of acquired competencies appropriate? 
Yes  
No    
Comment: 
 
 
 
14. Is the mechanism that will be used to obtain learners’ feedback on material learned 
appropriate? 
Yes 
No   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from: pedi.edtech – a faculty development program of the University of Texas 
Medical Brach and Galveston, with support from the US Department of Health and 
Human Services, Health Resources and Services Administration, Bureau of Health 
Professions. 
Comment: 
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Appendix C: Recommendations for Development of Education Material for Both 
Providers and Patients 
 
• Use simple wording and cartoon 
illustrations. This involves using 
language that can be understood 
by laymen. 
• Address common misconceptions 
and myths about HPV and HPV 
vaccination. Using evidence-based 
approaches can eliminate myths. 
Myths may negatively influence 
vaccine acceptance. 
• Use of visual aids and 
demonstrations as applicable. 
• Adopting modern technology as 
part of the education strategy is 
essential, for example the use of 
social media. 
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Appendix D: The ACE Star Model 
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Appendix E: Health Belief Model 
 
 
 
 
 
 
 
